Brimapitide Uses, Dosage, Side Effects and more
Brimapitide is under investigation in clinical trial NCT01570205 (Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers).
Trade Name | Brimapitide |
Generic | Brimapitide |
Brimapitide Other Names | Brimapitide |
Type | |
Formula | C164H286N66O40 |
Weight | Average: 3822.514 Monoisotopic: 3820.237428273 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |